Keeping Track: Mycapssa Stumbles; Carnexiv Returns; Keytruda Follows Opdivo In Hodgkin Lymphoma

 
• By Bridget Silverman

The latest drug development news and highlights from our FDA Performance Tracker.

More from United States

More from North America